These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37480330)

  • 1. Development of an integrated conceptual model of multiple sclerosis spasticity.
    Cameron MH; Bethoux F; Field-Fote E; Lenderking WR; Zaiser E; Cutts KN; Wagner JM; Berwaerts J; Steinerman JR
    Disabil Rehabil; 2024 Jun; 46(13):2955-2965. PubMed ID: 37480330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).
    Hobart JC; Riazi A; Thompson AJ; Styles IM; Ingram W; Vickery PJ; Warner M; Fox PJ; Zajicek JP
    Brain; 2006 Jan; 129(Pt 1):224-34. PubMed ID: 16280352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The meaning of spasticity to people with multiple sclerosis: what can health professionals learn?
    Morley A; Tod A; Cramp M; Mawson S
    Disabil Rehabil; 2013 Jul; 35(15):1284-92. PubMed ID: 23373525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M
    Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and Measurement of Spasticity in MS: State of the Evidence.
    Hugos CL; Cameron MH
    Curr Neurol Neurosci Rep; 2019 Aug; 19(10):79. PubMed ID: 31471769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported survey.
    Newsome SD; Thrower B; Hendin B; Danese S; Patterson J; Chinnapongse R
    Mult Scler Relat Disord; 2022 Dec; 68():104376. PubMed ID: 36544321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of symptoms associated with spasticity in patients with multiple sclerosis].
    Fernández-Pablos MA; Costa-Frossard L; García-Hernández C; García-Montes I; Escutia-Roig M;
    Enferm Clin; 2016; 26(6):367-373. PubMed ID: 27492746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.
    Trojano M; Celius EG; Donzé C; Izquierdo G; Patti F; Pöhlau D
    Eur Neurol; 2014; 72 Suppl 1():15-9. PubMed ID: 25278119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do cannabinoids reduce multiple sclerosis-related spasticity?
    Thaera GM; Wellik KE; Carter JL; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2009 Nov; 15(6):369-71. PubMed ID: 19901724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non pharmacological interventions for spasticity in multiple sclerosis.
    Amatya B; Khan F; La Mantia L; Demetrios M; Wade DT
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009974. PubMed ID: 23450612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.
    Meuth SG; Vila C; Dechant KL
    Expert Rev Neurother; 2015; 15(8):909-18. PubMed ID: 26166264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Physiotherapy Interventions on Spasticity in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Etoom M; Khraiwesh Y; Lena F; Hawamdeh M; Hawamdeh Z; Centonze D; Foti C
    Am J Phys Med Rehabil; 2018 Nov; 97(11):793-807. PubMed ID: 29794531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis.
    Carod-Artal FJ; Adjamian P; Vila Silván C; Bagul M; Gasperini C
    Expert Rev Neurother; 2022 Jun; 22(6):499-511. PubMed ID: 35582858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetic cost of walking and spasticity in persons with multiple sclerosis with moderate disability.
    Jeng B; Sandroff BM; Motl RW
    NeuroRehabilitation; 2018; 43(4):483-489. PubMed ID: 30400119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life Experiences of Patients With Multiple Sclerosis About Their Spasticity: A Phenomenological Study.
    Özkan İ; Polat Dunya C; Demir S
    Clin Nurs Res; 2023 Jan; 32(1):49-59. PubMed ID: 36154305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spasticity in multiple sclerosis: Associations with impairments and overall quality of life.
    Milinis K; Tennant A; Young CA;
    Mult Scler Relat Disord; 2016 Jan; 5():34-9. PubMed ID: 26856941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany.
    Henze T; von Mackensen S; Lehrieder G; Zettl UK; Pfiffner C; Flachenecker P
    Health Qual Life Outcomes; 2014 Aug; 12():119. PubMed ID: 25080934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.
    Gold R; Oreja-Guevara C
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):55-9. PubMed ID: 24289845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology and clinical assessment of spasticity in multiple sclerosis].
    Bensmail D; Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S45-50. PubMed ID: 22721364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.